| Charles Henry Herr, MD | |
|
Dartmouth-hitchcock Clinic, 1 Medical Center Drive, Lebanon, NH 03756 | |
| (603) 650-7254 | |
| Not Available |
| Full Name | Charles Henry Herr |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | Dartmouth-hitchcock Clinic, Lebanon, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962439422 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 7081 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Charles Henry Herr, MD 1 Medical Center Dr, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756 Ph: (603) 650-7254 | Charles Henry Herr, MD Dartmouth-hitchcock Clinic, 1 Medical Center Drive, Lebanon, NH 03756 Ph: (603) 650-7254 |
News Archive
A cytomegalovirus (CMV)-based vaccine provides long-lasting protective immunity against Ebola virus, and has potential for development as a disseminating vaccine strategy to prevent ebolavirus infection of wild African ape populations.
The Primary Care Development Corporation (PCDC), with support from HSBC Bank USA (HSBC), today announced a New Markets Loan Fund - $40 million in low-cost, long-term financing to develop primary care centers in economically distressed communities throughout New York State.
Harvard School of Public Health (HSPH) researchers have discovered that a particular type of protein (hormone) found in fat cells helps regulate how glucose (blood sugar) is controlled and metabolized (used for energy) in the liver.
Ruthigen, Inc., announced today enrollment of the first patient in a Randomized, Double-Blind Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal surgery.
CVRx, Inc., a private medical device company, introduced today its second-generation implantable device, the Barostim neo, for the treatment of uncontrolled hypertension. The Barostim neo features a new unilateral, 1mm electrode and a new smaller, more advanced stimulator to allow for more focused and efficient delivery of therapy. These improvements have led to shorter procedure times and extended longevity.
› Verified 2 days ago
Dr. Cecily Malise Reynolds, M.D., M.S. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Department Of Emergency Medicine, Lebanon, NH 03756 Phone: 603-650-7254 | |
Katherine Little, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Dept. Of Emer. Med., Lebanon, NH 03756 Phone: 603-650-7254 | |
Douglas A Deaett, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 125 Mascoma St, Lebanon, NH 03766 Phone: 603-448-3121 Fax: 603-448-7462 | |
Dr. Patricia L Lanter, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Dhmc - Dept Of Emergency Medicine, Lebanon, NH 03756 Phone: 603-650-7254 | |
Thomas W Trimarco, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Dhmc - Emergency Medicine, Lebanon, NH 03756 Phone: 603-650-7000 Fax: 603-650-4516 | |
Nancy Philips, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Drive, Dartmouth Hithcock Medical Center, Lebanon, NH 03756 Phone: 603-650-7254 | |
Jon Jordan Gray, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-7254 |